Stock Weekly: Medicenna Therapeutics (MDNA:CAD5.07) lifts 2.6% on low volume
CANADIAN WEEKLY STOCK REPORT
Medicenna Therapeutics Corp. (TSX:MDNA), Canada's 13th largest Biotechnology company by market cap, has increased 13.0c (or 2.6%) in the past week to close at CAD5.07. Compared with the S&P/TSX 60 Index which rose 4.1 points (or 0.4%) in the week, this represented a relative price increase of 2.2%.
The price ranged between a low of 4.8 on Wednesday, Dec 09 and a high of 5.03 on Monday, Dec 07. In the past week the market cap has risen by CAD6.4 million (...